To address this deficit, this study aims to provide insight into the symptom burden and severity through patient-reported outcome measurements and conduct an analysis of temporal trends and clinical consequences of symptom burden in patients with advanced lung cancer receiving combination immunotherapy. ...
Funding The research was supported by the Scientific Grant Agency of the Ministry of Education of Slovak Republic and the Slovak Academy of Sciences VEGA (Project No. 1/0017/20) (Changes in the Application of Managerial Functions in the Context of the Fourth Industrial Revolution and Adaptation ...
BMC Cancer (2018) 18:98 Page 10 of 11 OTR: Overall Toxicity Rate; PFS: Progression Free Survival; RAS: Rat sarcoma viral oncogene homolog; RECIST: Response Evaluation Criteria in Solid Tumors; SAE: Serious Adverse Event Acknowledgements Not applicable Funding The present study is an investigator...
Sections Figures References Abstract Introduction Results Discussion Methods Data availability Code availability References Acknowledgements Funding Author information Ethics declarations Peer review Additional information Supplementary information Source data Rights and permissions About this article AdvertisementNature...
investigation, initial draft writing, review, and editing. Wenzhe Feng and Hua Jiang played a role in methodology, software, and initial draft writing. Xianwen Cheng was responsible for conceptualization, supervision, project management, and funding acquisition. All authors read and approved the final...
Funding/Support: This work was supported in part by Agence Nationale de la Recherche (reference No. ANR-10- COHO-002) and Observatoire Français de la Sclérose en Plaques (OFSEP). Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection,...
Funding This work was supported by GSK (no grant number is applicable). Disclosure BMJ reports consulting fees from Acrivon Therapeutics, Adaptimmune, Agenus, Akesobio, Amgen, Aravive, AstraZeneca, Bayer, Clovis Oncology, Eisai, Elevar Therapeutics, EMD Serono, Genmab/Seagen, GOG Foundation, Grad...
Professors Guanghua Li have significantly contributed to the conception and design of this project and have also provided funding support for our research. Yifan Liu has been instrumental in data collection, implementing and refining the research methodology, building models and visualizing results, as ...
Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.Abstract Background Even though treatment failure is higher among TB and HIV infected children in a resource-limited setting, there is no prior evidence in general and in the study area...
To address this issue, a combined regimen of chemotherapy and radiotherapy has been recommended as the standard treatment strategy for locally advanced NPC (LA-NPC) [3]. However, the survival benefits of sequential chemotherapy for NPC patients are still controversial [4–8]. Induction chemotherapy...